← Leaderboards
Paul Beringer
University Of Southern California
$777,018
Attributed
$777,018
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $116.6K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$777,018 · 9
By mechanism
M01$777,018 · 9
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Caryn Lerman$95,133,528
- Yigal Arens$693,881
- Leslie A Lange$7,660,919
- Ian Michael Ehrenreich$5,351,686
- Suzanne Edmands$2,663,724
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchInstitutionResearch PersonnelResourcesFundingGrantUnited States National Institutes Of HealthSourceComputer Retrieval Of Information On Scientific Projects DatabaseCystic Fibrosis PatientsIothalamateKidneyDoseCystic FibrosisBloodPharmaceutical PreparationsProbenecidHuman SubjectHourLaboratoriesBlood SpecimenGenomicsCrossing Over, GeneticBiomarker
Grant awards (12)
EFFECTS OF PIOLITAZONE ON SPUTUM BIOMARKERS OF INFLAMMATION AND LUNG EPITHELI$32,464
M01 · FY2009 · RR · contact PI
IMPACT OF HIV WASTING AND LIPOSTROPHY ON PREDICTABILITY OF GLOMERULAR FILTRAT$22,695
M01 · FY2009 · RR · contact PI
EFFECT OF DOXYCYCLINE ON SPUTUM BIOMARKERS OF INFLAMMATION AND LUNG EPITHELIA$17,392
M01 · FY2009 · RR · contact PI
PHARMACOGENOMICS OF MDR1 IN PATIENTS WITH CYSTIC FIBROSIS (CF)$116,567
M01 · FY2008 · RR · contact PI
PHARMACOGENOMICS OF MDR1 IN PATIENTS WITH CYSTIC FIBROSIS (CF)$94,003
M01 · FY2007 · RR · contact PI
PHARMACOGENOMICS OF MDR1 IN PATIENTS WITH CYSTIC FIBROSIS (CF)$45,725
M01 · FY2006 · RR · contact PI
P-GLYCOPROTEIN AND RENAL CLEARANCE OF ANTIBIOTICS IN CF$6,532
M01 · FY2006 · RR · contact PI
P-GLYCOPROTEIN AND RENAL CLEARANCE OF ANTIBIOTICS IN CF$54,748
M01 · FY2005 · RR
"INTRACELLULAR PHARMACOKINETICS AND BIOAVAILABILITY OF AZITHROMYCIN CYSTIC FIB$40,285
M01 · FY2005 · RR
Intracellular Pharmacokinetics and bioavailability$244,977
M01 · FY2004 · RR
Bactericidal Activity of Gatifloxacin &Ampicillin$67,396
M01 · FY2004 · RR
P-glycoprotein and renal clearance of antibiotics in CF$34,234
M01 · FY2004 · RR